Cybin (HELP) Change in Cash (2020 - 2025)
Cybin (HELP) reported Change in Cash of -$883690.1 for Q1 2025, down 100.7% on a YoY basis from $126.2 million in Q1 2024, and up 95.53% quarter-over-quarter from -$19.8 million in Q4 2024.
Cybin (HELP) Change in Cash (2020 - 2025) Analysis & Trends
Cybin has reported Change in Cash for 6 years, with the latest figure at -$883690.1 in Q1 2025.
- For the quarter ending Q1 2025, Change in Cash fell 100.7% year-over-year to -$883690.1; the trailing twelve-month figure through Mar 2025 stood at -$79.2 million (down 155.58% YoY), and the FY2025 full-year result was -$53.2 million, down 137.28% from the prior year.
- Change in Cash for Q1 2025 stood at -$883690.1, up from -$19.8 million in the prior quarter.
- The five-year high for Change in Cash was $126.2 million in Q1 2024, with the low at -$39.8 million in Q3 2024.
- Historically, Change in Cash has averaged $2.2 million across 5 years, with a median of -$5.5 million in 2022.
- Annual changes were most pronounced in 2021 — Change in Cash soared 655.53% — and 2024, when it sank 715.38%.
- Cybin's Change in Cash stood at -$9.2 million in 2021, then soared by 39.8% to -$5.5 million in 2022, then jumped by 376.89% to $15.3 million in 2023, then sank by 228.84% to -$19.8 million in 2024, then jumped by 95.53% to -$883690.1 in 2025.
- The last three Change in Cash figures came in at -$883690.1 (Q1 2025), -$19.8 million (Q4 2024), and -$39.8 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -883,690.09 |
| Dec 31, 2024 | -19.76 Mn |
| Sep 30, 2024 | -39.77 Mn |
| Jun 30, 2024 | -18.80 Mn |
| Mar 31, 2024 | 126.15 Mn |
| Dec 31, 2023 | 15.34 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | -5.42 Mn |
| Feb 28, 2023 | -16.07 Mn |
| Dec 31, 2022 | -5.54 Mn |
| Sep 30, 2022 | -9.75 Mn |
| May 31, 2022 | 6.81 Mn |
| Feb 28, 2022 | -2.83 Mn |
| Dec 31, 2021 | -9.20 Mn |
| Sep 30, 2021 | 15.97 Mn |
| Jun 30, 2021 | -7.28 Mn |
| Dec 31, 2020 | 27.74 Mn |
| Sep 30, 2020 | -2.87 Mn |
| Jun 30, 2020 | 4.44 Mn |